2011Chinese Journal of Clinical GastroenterologyRequires access

Application of Model for End-stage Liver Disease in Assessing the Prognosis of the Patients with Chronic Severe Hepatitis

Jinke Li

Open publisher page 0 citations

Abstract

Objective To study the clincal pratical use of the model for end-stage liver disease(MELD) and assess its validity in predicting the prognosis of patients with chronic severe hepatitis.Methods 125 patients with chronic severe hepatitis were graded with MELD formula.The motality rates was observed within three months.The validity of MELD was determined and the optimal cut-off values of the model to discriminate between deceased and surviving patients were calculated by ROC curves and area under the curve.Results 81 patients(64.8%) died within 3 month.MELD score of non-survivors(34.6±10.5) was higher than that of survivors(23.5±5.8) significantly(P0.001).The mortality rates of patients whose MELD20,20≤MELD30,30≤MELD40 and MLED≥40 were 14.3%,54.9%,79.5% and 95.2% respectively.The optimal cut-off values of MELD to predict the prognosis of patients was 26,whose c-statjstic,sensitivity,specificity,accuracy and were 0.802,80.2%,79.5% and 80.0% respectively.Conclusion The mortality of the patients increase with the increase of their MELD scores.The MELD can accurately predict the short-term prognisis of patients with chronic sever hepatitis.

About this research paper

What this paper is about

Objective To study the clincal pratical use of the model for end-stage liver disease(MELD) and assess its validity in predicting the prognosis of patients with chronic severe hepatitis.Methods 125 patients with chronic severe hepatitis were graded with MELD formula.The motality rates was observed within three months.The validity of MELD was determined and the optimal cut-off values of the model to discriminate between deceased and surviving patients were calculated by ROC curves and area under the curve.Results 81 patients(64.8%) died within 3 month.MELD score of non-survivors(34.6±10.5) was higher than that of survivors(23.5±5.8) significantly(P0.001).The mortality rates of patients whose MELD20,20≤MELD30,30≤MELD40 and MLED≥40 were 14.3%,54.9%,79.5% and 95.2% respectively.The optimal cut-off values of MELD to predict the prognosis of patients was 26,whose c-statjstic,sensitivity,specificity,accuracy and were 0.802,80.2%,79.5% and 80.0% respectively.Conclusion The mortality of the patients increase with the increase of their MELD scores.The MELD can accurately predict the short-term prognisis of patients with chronic sever hepatitis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the clincal pratical use of the model for end-stage liver disease(MELD) and assess its validity in predicting the prognosis of patients with chronic severe hepatitis.Methods 125 patients with chronic severe hepatitis were graded with MELD formula.The motality rates was observed within three months.The validity of MELD was determined and the optimal cut-off values of the model to discriminate between deceased and surviving patients were calculated by ROC curves and area under the curve.Results 81 patients(64.8%) died within 3 month.MELD score of non-survivors(34.6±10.5) was higher than that of survivors(23.5±5.8) significantly(P0.001).The mortality rates of patients whose MELD20,20≤MELD30,30≤MELD40 and MLED≥40 were 14.3%,54.9%,79.5% and 95.2% respectively.The optimal cut-off values of MELD to predict the prognosis of patients was 26,whose c-statjstic,sensitivity,specificity,accuracy and were 0.802,80.2%,79.5% and 80.0% respectively.Conclusion The mortality of the patients increase with the increase of their MELD scores.The MELD can accurately predict the short-term prognisis of patients with chronic sever hepatitis.

Key concepts: Medicine, Internal medicine, Liver disease, Hepatitis a virus, Stage (stratigraphy), Chronic hepatitis, Model for End-Stage Liver Disease, Hepatitis

Related papers

Back to paper searchBrowse research topicsOriginal source
Application of Model for End-stage Liver Disease in Assessing the Prognosis of the Patients with Chronic Severe Hepatitis — Research Paper | ScholarLens